Updated: March 1, 2026

What Is Drizalma Sprinkle? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Summarize with AI

Brand Name, Generic Name, and Drug Class
What Is Drizalma Sprinkle Used For?
Dosage Forms and Available Strengths
How to Take Drizalma Sprinkle
Typical Dosing by Condition
Key Facts Every Patient Should Know
Finding Drizalma Sprinkle in 2026

Drizalma Sprinkle is a brand-name duloxetine SNRI used for depression, anxiety, fibromyalgia, and pain. Here's everything you need to know in 2026.

Drizalma Sprinkle is the brand name for a unique formulation of duloxetine — a widely used antidepressant in the SNRI (serotonin-norepinephrine reuptake inhibitor) class. What makes Drizalma Sprinkle distinct is that its capsule can be opened and the contents sprinkled onto food, making it the only duloxetine option specifically designed for patients who cannot swallow whole capsules. Here's everything you need to know.

Brand Name, Generic Name, and Drug Class

Drizalma Sprinkle is the brand name. The generic name is duloxetine. Other brand names that contain duloxetine include Cymbalta (the original and most well-known brand) and Irenka. Drizalma Sprinkle belongs to the drug class of serotonin-norepinephrine reuptake inhibitors (SNRIs). It is manufactured by Sun Pharmaceutical Industries.

As of 2026, there is no FDA-approved generic version of the Drizalma Sprinkle sprinkle-capsule formulation, making it a brand-name-only product. Generic duloxetine is available in standard delayed-release capsules, but these are a different formulation and cannot be opened.

What Is Drizalma Sprinkle Used For?

Drizalma Sprinkle is FDA-approved for the following conditions:

Major Depressive Disorder (MDD) — In adults. Helps improve mood, energy, sleep, and interest in daily activities.
Generalized Anxiety Disorder (GAD) — In adults and children ages 7 and older. This is a key pediatric use where the sprinkle feature is especially valuable.
Diabetic Peripheral Neuropathy — In adults. Reduces the burning, tingling, and pain caused by nerve damage from diabetes.
Fibromyalgia — In adults only (Drizalma Sprinkle). Helps manage widespread pain, fatigue, and sleep problems.
Chronic Musculoskeletal Pain — Including low back pain and osteoarthritis pain in adults.

Off-label uses (not FDA-approved but sometimes prescribed) include neuropathic pain from other causes, binge eating disorder, chemotherapy-induced peripheral neuropathy, and stress urinary incontinence.

Dosage Forms and Available Strengths

Drizalma Sprinkle is available as a delayed-release sprinkle capsule in the following strengths:

20 mg — Starter dose for some patients, also used when tolerability is a concern
30 mg — Common starting dose for MDD and fibromyalgia titration
40 mg — Used as a starting dose for MDD (20 mg twice daily)
60 mg — Most common maintenance dose for MDD, fibromyalgia, and pain

How to Take Drizalma Sprinkle

Drizalma Sprinkle can be taken in one of three ways:

Swallow whole. If you can swallow the capsule intact, do so with or without food. Do not crush or chew.
Sprinkle on applesauce. Open the capsule and sprinkle the pellets onto 1 tablespoon of applesauce. Swallow the mixture immediately without chewing. Do not save for later.
Via nasogastric tube. Add pellets to an all-plastic syringe with 50 mL water, shake 10 seconds, administer through a 12 French or larger NG tube.

Take Drizalma Sprinkle at the same time(s) each day. It is typically taken once or twice daily depending on your indication and dose. You do not need to take it with food, but food may help reduce nausea.

Typical Dosing by Condition

MDD: Start at 30–60 mg once daily. Some doctors start at 20 mg twice daily; maximum is 120 mg/day.
GAD: 60 mg once daily in adults; elderly patients start at 30 mg/day. Pediatric dosing determined by weight and age.
Fibromyalgia: Start 30 mg once daily x 1 week, then increase to 60 mg once daily.
Diabetic neuropathy: 60 mg once daily.
Chronic musculoskeletal pain: 60 mg once daily.

Key Facts Every Patient Should Know

Not a controlled substance — no DEA restrictions on prescribing or refilling
Takes 4–6 weeks to see full antidepressant/anxiety benefit; pain relief may come sooner
Do not stop abruptly — requires gradual tapering under medical supervision
Avoid alcohol — increases liver damage risk
Carries a boxed warning about suicidal thoughts in patients under 25
Retail cost approximately $226–$273/month; coupons available for significant savings

Finding Drizalma Sprinkle in 2026

Because Drizalma Sprinkle is a single-source brand-name product, it can be harder to locate than generic medications. If you're having trouble finding it at your pharmacy, use medfinder to search nearby pharmacies with current stock. And be sure to read our guide on how to save money on Drizalma Sprinkle — the retail price can be reduced significantly with the right coupon.

Frequently Asked Questions

Both Drizalma Sprinkle and Cymbalta contain the same active ingredient (duloxetine). The key difference is the formulation: Drizalma Sprinkle is a sprinkle capsule that can be opened and administered on applesauce or via NG tube. Cymbalta's delayed-release capsules are NOT designed to be opened. If you need to sprinkle the contents, only Drizalma Sprinkle is appropriate.

For depression and anxiety, most patients begin to notice improvement in sleep, energy, or appetite within 1–2 weeks, but full benefit typically takes 4–6 weeks. For pain conditions (fibromyalgia, diabetic neuropathy), some relief may be felt within the first 1–2 weeks, with full effect over 4–8 weeks.

Yes. Drizalma Sprinkle is FDA-approved for treating generalized anxiety disorder in children 7 years of age and older. The sprinkle feature is particularly useful for children who cannot swallow capsules. It is not approved in children for depression, diabetic neuropathy, or fibromyalgia.

Coverage varies by insurance plan. Drizalma Sprinkle is typically placed on a higher tier (Tier 3 or above) because it is a brand-name drug with no generic equivalent. Most plans require a prior authorization documenting the medical necessity of the sprinkle formulation. Call your insurance or your prescriber's office for help with PA paperwork.

Avoid alcohol (increases liver damage risk), MAOIs within 14 days of starting or stopping duloxetine (risk of serotonin syndrome), NSAIDs or blood thinners without consulting your doctor (bleeding risk), and driving or operating heavy machinery until you know how the medication affects you. Do not stop the medication abruptly without medical guidance.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards